PRINCETON, N.J., March 16 /PRNewswire/ -- Tickerspy
(http://www.tickerspy.com), an investing website featuring over 250
unique, proprietary Indexes, announced the creation of the Chinese
Healthcare Stocks Index, which includes among its components
American Oriental Bioengineering (NYSE: AOB), Sinovac Biotech
(Nasdaq: SVA), Mindray Medical International (NYSE: MR), China
Medical Technologies (Nasdaq: CMED), WuXi PharmaTech (NYSE: WX),
China Sky One Medical (Nasdaq: CSKI), Tianyin Pharmaceutical (AMEX:
TPI), China-Biotics (Nasdaq: CHBT), and several others.
The Chinese Healthcare Stocks Index is up more than 5% over the
last month as earnings throughout the segment have moved the
component stocks. The Index is up by nearly 30% versus the
S&P 500 since the start of 2008. To gain immediate access
the Chinese Healthcare Stocks Index, a complete list of its
components, and various charts and related metrics, visit the
following link:
http://www.tickerspy.com/index/Chinese-Healthcare-Stocks?refer=prn2
Tickerspy Indexes use a "net asset value" calculation and cover
a wide range of market sectors and segments, including dry bulk
shipping stocks, Canadian energy trusts, gold and silver stocks,
uranium stocks, money center banks, and many more. Tickerspy
also offers ten different Chinese Indexes, including for Chinese
Solar stocks, Chinese IT stocks, and Chinese agriculture
stocks.
About tickerspy:
Tickerspy is a free, stock market-focused website that lets
users track proprietary Indexes and institutional holdings.
Tickerspy members can also track each other's portfolios and
share investment ideas and news. In addition, tickerspy
members receive a free, customized daily email that includes
portfolio performance, alerts, and news on the stocks they are
tracking.
NOTE: This release was published by Indie Research Advisors,
LLC, a registered investment advisor with CRD #131926.
Interested parties may visit adviserinfo.sec.gov for
additional information. Past performance does not guarantee
future results. Investors should always research companies and
securities before making any investments. Nothing herein should be
construed as an offer or solicitation to buy or sell any
security.
CONTACT: Marcia Martin,
tickerspy, +1-888-278-5515
SOURCE Indie Research Advisors, LLC